Breast cancer - Interaction between ethnicity and environment

In Vivo

Volumn 14, Issue 1, 2000, Pages 115-123

  Maskarinec, Gertraud ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Breast; Environment; Ethnicity; Etiology; Incidence; Neoplasms; Risk factors; Trends

Indexed keywords

CARCINOGEN; ENZYME; ESTROGEN; GROWTH FACTOR; HORMONE; INSULIN;

ASIA; BREAST CANCER; CANCER RISK; DIET; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; GENETIC POLYMORPHISM; HUMAN; JAPAN; MIGRATION; REVIEW; RISK FACTOR; UNITED STATES;

EID: 0034112133     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (111)

1. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, eds. C15VII: Electronic database of cancer incidence in five continents Vol. VII (IARC Scientific Publications No. 143). Lyon, France: International Agency for Research on Cancer, 1997.
2. Haenszel W, Kurihara M: Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 40: 43-68, 1968.
3. MacMahon B, Cole P, Brown J: Etiology of human breast cancer: a review. J Natl Cancer Inst 50: 21-42, 1973.
4. Wakai K, Suzuki S, Ohno Y, Kawamura T, Tamakoshi A, Aoki R: Epidemiology of breast cancer in Japan. Int J Epidemiol 24: 285-91, 1995.
5. Minami Y, Takano A, Okuno Y, Fukao A, Kurihara M, Hisamichi S: Trends in the incidence of female breast and cervical cancers in Miyagi Prefecture, Japan, 1959-1987. Jpn J Cancer Res 87: 10-7, 1996.
6. Ministry of Health and Welfare. Annual report on health statistics for Japan, Tokyo, Japanese Government, 1998.
7. Miller BA, Kolonel LN, Bernstein L. et al: Racial/ethnic patterns of cancer in the United States 1988-1992. National Cancer Institute. NIH Pub. No. 96-4104. Bethesda, MD.
8. Oyama N, Johnson DB: Hawaii health surveillance program survey methods and procedures. Hawaii State Department of Health. R & S Report No. 54, 1986.
9. Quisenberry WB, Bruyere PT, Rogers M: Ethnic differences in cancer in Hawaii. Prog Clin Cancer 4: 48-61, 1970.
10. Hinds MW, Kolonel LN, Nomura AM, Burch TA, Rellahan W: 1973-77 cancer incidence in Hawaii, with special reference to trends since 1968-72 for certain sites. Hawaii Med J 40: 7-11, 1981.
11. Kolonel LN. Cancer incidence among Filipinos in Hawaii and the Philippines. Natl Cancer Inst Monogr 69: 93-8, 1985.
12. Ries LAG, Miller BA, Hankey BF, Kosary CL, Harras A, Edwards BK, eds. SEER cancer statistics review, 1973-1991: tables and graphs. Bethesda. MD: National Cancer Institute. NIH Pub. No. 94-2789, 1994.
13. Maskarinec G, Meng L, Wilkens LR: Mammography screening and the increase in breast cancer incidence in Hawaii. Cancer Epidemiol. Biomarkers Prev 6: 201-8, 1997.
14. Seow A, Duffy SW, McGee MA, Lee J, Lee HP: Breast cancer in Singapore: trends in incidence 1968-1992. Int J Epidemiol 25: 40-5, 1996.
15. Dunn JE Jr: Breast cancer among American Japanese in the San Francisco Bay area. Natl Cancer Inst Monogr 47: 157-60, 1977.
16. Thomas DB, Karagas MR: Cancer in first and second generation Americans. Cancer Res 47: 5771-6, 1987.
17. Nordyke EC: The peopling of Hawaii. 2nd ed. Honolulu: University of Hawaii Press, 1989.
18. Kolonel LN, Hinds MW, Hankin JH: Cancer patterns among migrant and native-born Japanese in Hawaii in relation to smoking, drinking, and dietary habits. In: Gelboin HV, MacMahon B, Matsushima T, eds. Genetics and Environmental Factors in Experimental and Human Cancer. Baltimore: University Park Press, 1980: 327-40.
19. Buell P: Changing incidence of breast cancer in Japanese-American women. J Natl Cancer Inst 51: 1479-83, 1973.
20. Ziegler RG, Hoover RN, Pike MC, et al: Migration Patterns and breast cancer risk in Asian- American women. J Natl Cancer Inst 85: 1819-27, 1993.
21. Henderson BE, Pike MC, Bernstein L, Ross RK: Breast cancer. In: Schottenfeld D, Fraumeni JFJ, eds. Cancer epidemiology and prevention. 2nd ed. New York: Oxford University Press, 1996: 1022-39.
22. Goodman MT, Cologne JB, Moriwaki H, Vaeth M, Mabuchi K. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors. Prev Med 26: 144-53, 1997.
23. Liu L, Deapen D, Bernstein L. Socioeconomic status and cancers of the female breast and reproductive organs: a comparison across racial/ethnic populations in Los Angeles County, California (United States). Cancer Causes Control 9: 369-80, 1998.
24. Wolff MS, Toniolo PG, Lee EW, Rivera M, Dubin N. Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst 85: 648-52, 1993.
25. Krieger N, Wolff MS, Hiatt RA, Rivera M, Vogelman J, Orentreich N. Breast cancer and serum organochlorines: a prospective study among White, Black, and Asian women. J Natl Cancer Inst 86: 589-99, 1994.
26. Bonnet M, Guinebretiere J-M, Kremmer E, et al: Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 91: 1376-81, 1999.
27. Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG: 'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature 303: 767-70, 1983.
28. Henderson BE, Ross RK, Pike MC, Casagrande JT: Endogenous hormones as a major factor in human cancer. Cancer Res 42: 3232-9, 1982.
29. Wynder EL, Fujita Y, Harris RE, Hirayama T, Hiyama T. Comparative epidemiology of cancer between the United States and Japan. A second look. Cancer 67: 746-63, 1991.
30. Dickinson LE, MacMahon B, Cole P, Brown JB: Estrogen profiles of Oriental and Caucasian women in Hawaii. N Engl J Med 291: 1211-3, 1974.
31. Goldin BR, Adlerereutz H, Gorbach SL, et al: The relationship between estrogen levels and diets of Caucasian American and Oriental immigrant women. Am J Clin Nutr 44: 945-53, 1986.
32. Key TJA, Chen J, Wang DY, Pike MC, Boreham J: Sex hormones in women in rural China and Britain. Br J Cancer 62: 631-6, 1990.
33. Shimizu H, Ross RK, Bernstein L, Pike M, Henderson BE: Serum oestrogen levels in postmenopausal women: comparison of American whites and Japanese in Japan. Br J Cancer 62: 451-3, 1990.
34. Trichopoulos D, Yen S, Brown J, Cole P, MacMahon B: The effect of westernization on urine estrogens, frequency of ovulation, and breast cancer risk. A study of ethnic Chinese women in the Orient and the USA. Cancer 53: 187-92, 1984.
35. Goodman MJ, Bulbrook RD, Moore JW: The distribution of estradiol in the sera of normal Caucasian, Chinese, Filipina, Hawaiian and Japanese women living in Hawaii. Eur J Cancer Clin Oncol 24: 1855-60, 1988.
36. Nomura AM, Kolonel LN, Hirohata T, Lee J: The association of replacement estrogens with breast cancer. Int J Cancer 37: 49-53, 1986.
37. Pike MC, Spicer DV, Dahmoush L, Press MF: Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15: 17-35, 1993.
38. Gail MH, Fears TR, Hoover RN, et al: Reproducibility studies and interlaboratory concordance for assays of serum hormone levels: estrone, estradiol, estrone sulfate, and progesterone. Cancer Epidemiol, Biomarkers Prev 5: 835-44, 1996.
39. Falk RT, Gail MH, Fears TR, et al: Reproducibility and validity of radioimmunoassays for urinary hormones and metabolites in pre- and postmenopausal women. Cancer Epidemiol, Biomarkers Prev 8: 567-77, 1999.
40. Kabat GC, Chang CJ, Sparano JA, et al: Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiol. Biomarkers Prev 6: 505-9, 1997.
41. Ursin G, London S, Stanczyk FZ, et al: Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 91: 1067-72, 1999.
42. Nebert DW: Elevated estrogen 16α-hydroxylase activity: is this a genotoxic or nongenotoxic biomarker in human breast cancer risk? J Natl Cancer Inst 85: 1888-91, 1993.
43. Yager JD, Liehr JG: Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 36: 203-32, 1996.
44. Bradlow HL, Davis DL, Lin G, Sepkovic D, Tiwari RN Effects of pesticides on the ratio of 16alpha/2-hydroxyestrone: a biologic marker of breast cancer risk. Environ Health Perspect 103(Suppl 7): 147-50, 1995.
45. Adlercreutz H, Gorbach SL, Goldin BR, Woods MN, Dwyer JT, Hamalainen E: Estrogen metabolism and excretion in Oriental and Caucasian women. J Natl Cancer Inst 86: 1076- 82, 1994.
46. Ho GH, Luo XW, Ji CY, Foo SC, Ng EH: Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk. Ann Acad Med Singapore 27: 294-9, 1998.
47. Hu Y-H, Nagata C, Shimizu H, Kaneda N, Kashiki Y: Association of body mass index, physical activity, and reproductive histories with breast cancer: a case-control study in Gifu, Japan. Breast Cancer Res Treat 43: 65-72, 1997.
48. Wu AH, Ziegler RG, Pike MC, et al: Menstrual and reproductive factors and risk of breast cancer in Asian-Americans. Br J Cancer 73: 680-6, 1996.
49. Nomura AMY, Lee J, Kolonel LN, Hirohata T: Breast cancer in two populations with different levels of risks for the disease. Am J Epidemiol 119: 496-502, 1984.
50. Madigan MP, Ziegler RG, Benichou J, Byrne C, Hoover RN: Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 87: 1981-5, 1995.
51. Rockhill B, Weinberg CR, Newman B: Population attributable fraction estimation for established breast cancer risk factors: considering the issues of high prevalence and unmodifiability. Am J Epidemiol 147: 826-33, 1998.
52. Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C: Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol 122: 904-14, 1985.
53. Seidman H, Stellman SD, Mushinski MH: A different perspective on breast cancer risk factors: some implications of the nonattributable risk. CA Cancer J Clin 32: 301-13, 1982.
54. Smith-Warner SA, Spiegelman D, Hunter DJ, for the Pooling Project of Prospective Studies of Diet and Cancer Investigators. Population attributable risk of breast cancer due to reproductive factors (Abstract). Cancer Epidemiol. Biomarkers Prev 7: 176, 1948.
55. Le Marchand L, Kolonel LN, Earle ME, Mi MP. Body size at different periods of life and breast cancer risk. Am J Epidemiol 128: 137-52, 1988.
56. Ziegler RG, Hoover RN, Nomura AMY, et al: Relative weight, weight change, height, and breast cancer risk in Asian-American women. J Natl Cancer Inst 88: 650-60, 1996.
57. Hunter DJ, Willett WC, Diet, body size, and breast cancer. Epidemiol Rev 15: 110-32, 1993.
58. Hirose K, Tajima K, Hamajima N, et al: Effect of body size on breast-cancer risk among Japanese women. Int J Cancer 80: 349-55, 1999.
59. Kolonel LN, Nomura AM, Lee J, Hirohata T: Anthropometric indicators of breast cancer risk in postmenopausal women in Hawaii. Nutr Cancer 8: 247-56, 1986.
60. Trichopoulos D, Lipman RD. Mammary gland mass and breast cancer risk. Epidemiology 3: 523-6, 1992.
61. Willett W: Nutritional epidemiology, 2nd ed. New York: Oxford University Press, 1998: 377-413.
62. Kolonel LN, Hankin JH, Nomura AM, Hinds MW: Studies of nutrients and their relationship to cancer in the multiethnic population of Hawaii. Adv Exp Med Biol 206: 35-43, 1986.
63. Kolonel LN, Nomura AMY, Hinds MW, Hirohata T, Hankin JH, Lee J: Role of diet in cancer incidence in Hawaii. Cancer Res 43 (Suppl): 2397s-402s, 1983.
64. Hirohata T, Nomura AMY, Hankin JH, Kolonel LN, Lee J: An epidemiologic study on the association between diet and breast cancer. J Natl Cancer Inst 78: 595-600, 1987.
65. Goodman MT, Nomura AMY, Wilkens LR, Hankin JH: The association of diet, obesity, and breast cancer in Hawaii. Cancer Epidemiol, Biomarkers Prev 1: 269-75, 1992.
66. Adlercreutz H: Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest 2014: 3-23,1990.
67. Messina M, Barnes S: The role of soy products in reducing risk of cancer. J Natl Cancer Inst 83: 541-6,1991.
68. Nomura AMY, Henderson BE, Lee J. Breast cancer and diet among Japanese in Hawaii. Am J Clin Nutr. 31: 2020-5,1978.
69. Wu AH, Ziegler RG, Horn-Ross PL, et al: Tofu and risk of breast cancer in Asian-Americans. Cancer Epidemiol Biomarkers Prev 5: 901-6,1996.
70. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE: Dietary effects on breast-cancer risk in Singapore. Lancet 337: 1197-200, 1991.
71. Yuan JM, Wang Q-S, Ross RK, Henderson BE, Yu MC: Diet and breast cancer in Shanghai and Tianjin, China. Br J Cancer 71: 1353-8,1995.
72. Freudenheim JL, Marshall JR, Vena JE, et al: Premenopausal breast cancer risk and intake of vegetables, fruits, and related nutrients. J Natl Cancer Inst 88: 340-8,1996.
73. Longnecker MP, Newcomb PA, Mittendorf R. et al: Risk of breast cancer in relation to lifetime alcohol consumption. J Natl Cancer Inst 87: 423-9, 1995.
74. Stoll BA. Essential fatty acids, insulin resistance, and breast cancer risk. Nutr Cancer 31: 72-7, 1998.
75. Del Giudice ME, Fantus IG, Ezzat S, McKeown-Eyssen G, Page D, Goodwin PJ. Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res. Treat 47: 111-20, 1998.
76. Hankinson SE, Willett WC, Colditz GA, et al: Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351: 1393-6, 1998.
77. Kazer RR: Insulin resistance, insulin-like growth factor I and breast cancer: a hypothesis. Int J Cancer 62: 403-6, 1995.
78. Hara H, Egusa G, Yamakido M, Kawate R: The high prevalence of diabetes mellitus and hyperinsulinemia among the Japanese-Americans living in Hawaii and Los Angeles. Diabetes Res Clin Pract 24 Suppl: S37-42, 1994.
79. Klonoff-Cohen HS, Schaffroth LB, Edelstein SL, Molgaard C, Saltzstein SL: Breast cancer histology in Caucasians, African Americans, Hispanics, Asians, and Pacific Islanders. Ethn Health 3: 189-98, 1998.
80. Stemmermann GN: The pathology of breast cancer in Japanese women compared to other ethnic groups: a review. Breast Cancer Res Treat 18 Suppl 1: S67-72, 1991.
81. Krieger N, van den Eeden SK, Zava D, Okamoto A: Race/ethnicity, social class, and prevalence of breast cancer prognostic biomarkers: a study of white, black, and Asian women in the San Francisco Bay area. Ethn Dis 7: 137-49, 1997.
82. Gilliland FD: Ethnic differences in cancer incidence: a marker for inherited susceptibility? Environ Health Perspect 105 Suppl 4: 897-900, 1997.
83. Brody LC, Biesecker BB: Breast cancer susceptibility genes. BRCA1 and BRCA2. Medicine (Baltimore) 77: 208-26, 1998.
84. Struewing JP, Hartge P, Wacholder S, et al: The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336: 1401-8, 1997.
85. Weston A, Pan CF, Ksieski HB, et al: p53 haplotype determination in breast cancer. Cancer Epidemiol, Biomarkers Prev 6: 105-12, 1997.
86. Hartmann A, Blaszyk H, Saitoh S, et al: High frequency of p53 gene mutations in primary breast cancers in Japanese women, a low-incidence population. Br J Cancer 73: 896-901, 1996.
87. Perera FP. Molecular epidemiology in cancer prevention. In: Schottenfeld D, Fraumeni JF, eds. Cancer Epidemiology and Prevention. 2nd ed. New York, Oxford: Oxford University Press, 1996: 101-15.
88. Le Marchand L, Sivaraman L, Pierce L, et al: Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res 58: 4858-63, 1998.
89. Shields PG: Pharmacogenetics: detecting sensitive populations. Environ Health Perspect 102 Suppl 11: 81-7, 1994.
90. Le Marchand L, Kolonel LN: [Cancer in Japanese migrants to Hawaii: interaction between genes and environment]. Rev Epidemiol Sante Publique 40: 425-30, 1992.
91. Michnovicz JJ, Bradlow HL: Altered estrogen metabolism and excretion in humans following consumption of indole-3-carbinol. Nutr Cancer 16: 59-66, 1991.
92. Shapiro TA, Fahey JW, Wade KL, Stephenson KK, Talalay P: Human metabolism and excretion of cancer chemoprotective glucosinolates and isothiocyanates of cruciferous vegetables. Cancer Epidemiol, Biomarkers Prev 7: 1091-100, 1998.
93. Obermeier MT, White RE, Yang CS: Effects of bioflavonoids on hepatic P450 activities. Xenobiotica 25: 575-84, 1995.
94. Lavigne JA, Helzlsouer KJ, Huang HY, et al: An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res 57: 5493-7, 1947.
95. Bailey LR, Roodi N, Verrier CS, Yee CJ, Dupont WD, Parl FF: Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. Cancer Res 58: 65-70, 1998.
96. Bailey LR, Roodi N, Dupont WD, Parl FF: Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Cancer Res 58: 5038-41, 1998.
97. Feigelson HS, Coetzee GA, Kolonel LN, Ross RK, Henderson BE: A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res 57: 1065-5, 1997.
98. Ambrosone CB, Freudenheim JL, Graham S, et al: Cigarette smoking. N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA 276: 1444-501, 1996.
99. Huang CS, Chern HD, Shen CY, Hsu SM, Chang KJ: Association between N-acetyltransferase 2 (NAT2) genetic polymorphism and development of breast cancer in post-menopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence. Int J Cancer 82: 175-9, 1999.
100. Le Marchand L, Wilkinson GR, Wilkens LR. Genetic and dietary predictors of CYP2E1 activity: a phenotyping study in Hawaii Japanese using chorzoxazone. Cancer Epidemiol, Biomarkers Prev 8: 445-500, 1999.
101. Le Marchand L, Sivaraman L, Franke AA, et al: Predictors of N-acetyltransferase activity: should caffeine phenotyping and NAT2 genotyping be used interchangeably in epidemiological studies? Cancer Epidemiol. Biomarkers Prev 5: 449-55, 1996.
102. Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ: Mammographic densities and breast cancer risk. Cancer Epidemiol, Biomarkers Prev 7: 1133-44, 1998.
103. Boyd NF, Byng JW, Jong RA, et al: Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 87: 670-5, 1995.
104. Kojima O, Majima T, Uehara Y, et al: Radiographic parenchymal patterns in Japanese females as a risk factor for breast carcinoma. World J Surg 8: 414-8, 1984.
105. Maskarinec G, Meng L, Shimozuma K: A pilot study of mammographic density patterns among Japanese women. J Epidemiol 9: 73-7, 1999.
106. Gravelle IH, Bulbrook RD, Wang DY, et al: A comparison of mammographic parenchymal patterns in premenopausal Japanese and British women. Breast Cancer Res Treat 18: S43-5, 1991.
107. Grove JS, Goodman MJ, Gilbert FI, Mi MP: Factors associated with mammographic pattern. Br J Radiol 58: 21-5, 1985.
108. Feuer EJ, Wun LM. How much of the recent breast cancer incidence can be explained by increases in mammography utilization? A dynamic population model approach. Am J Epidemiol 136: 1423-36, 1992.
109. Saltzstein SL: The association of ethnicity and the incidence of mammary carcinoma in situ in women: 11,436 cases from the California Cancer Registry. Cancer Detect Prev 21: 361-4, 1997.
110. Hawaii Department of Health. Health Promotion and Education Branch. Hawaii's health risk behaviors, 1993. Honolulu, HI: Hawaii Department of Health, 1945.
111. Serxner S, Chung CS: Trend analysis of social and economic indicators of mammography use in Hawaii. Am J Prev Med 8: 303-8, 1992.